Evidence map›Paper›PMID 30775480›Full record

ReviewOsteoporosis and sarcopenia2016

The role of sex steroid hormones in the pathophysiology and treatment of sarcopenia.

Yong Jin Kim, Amin Tamadon, Hyun Tae Park, Hoon Kim, Seung-Yup Ku

Abstract readReview
In one paragraph

Review in Osteoporosis and sarcopenia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Androgens as the "old age stick" in skeletal muscle.Cell communication and signaling : CCS · 2025
    Review
  11. Article
  12. Article
  13. Estrogen-related Receptor Signaling in Skeletal Muscle Fitness.International journal of sports medicine · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. The sex-specific prognostic utility of sarcopenia in cirrhosis.Journal of cachexia, sarcopenia and muscle · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yong Jin KimDepartment of Obstetrics and Gynecology, Korea University Guro Hospital, South Korea.
Amin TamadonDepartment of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, South Korea.
Hyun Tae ParkDepartment of Obstetrics and Gynecology, Korea University Anam Hospital, Korea University College of Medicine, South Korea.
Hoon KimDepartment of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, South Korea.
Seung-Yup KuDepartment of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sex steroids influence the maintenance and growth of muscles. Decline in androgens, estrogens and progesterone by aging leads to the loss of muscular function and mass, sarcopenia. These steroid hormones can interact with different signaling pathways through their receptors. To date, sex steroid hormone receptors and their exact roles are not completely defined in skeletal and smooth muscles. Although numerous studies focused on the effects of sex steroid hormones on different types of cells, still many unexplained molecular mechanisms in both skeletal and smooth muscle cells remain to be investigated. In this paper, many different molecular mechanisms that are activated or inhibited by sex steroids and those that influence the growth, proliferation, and differentiation of skeletal and smooth muscle cells are reviewed. Also, the similarities of cellular and molecular pathways of androgens, estrogens and progesterone in both skeletal and smooth muscle cells are highlighted. The reviewed signaling pathways and participating molecules can be targeted in the future development of novel therapeutics.

Indexed as

AndrogenEstrogenProgesteroneSarcopeniaSkeletal muscleSmooth muscle

Identifiers

PMID30775480
PMCPMC6372754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.